Replies to post #17002 on Cytogenix (fka CYGX)

[Paulness]

Holycow cygx expected to do this in-life proof-of-principle ,IMHO they were pleasantly surprised and proud that such a small dose of their product works ,and this small dose affects the virus, what will a greater dose do? Cytogenix knows this is great news ,we the public tend to dissect a PR to the point where we turn a positive into a negative .Again lets not scare each other out of our future.


Dr. Malcolm Skolnick, CytoGenix president and CEO, commented, "This is the first in a series of in-life proof-of-principle data we expected based on our earlier observations in cell culture where Simplivir(TM) reduced viral titer load up to 500-fold. These data extend the validation of CytoGenix' proprietary delivery method for topical administration of plasmid DNA-based therapeutics."